| Literature DB >> 30960054 |
Masahiko Minoda1, Tomomi Otsubo2, Yohei Yamamoto3, Jianxin Zhao4, Yoshitomo Honda5, Tomonari Tanaka6, Jin Motoyanagi7.
Abstract
This study concerned the controlled synthesis of periodic glycopolymers by reversible addition-fragmentation chain transfer (RAFT) copolymerization. To this end, maltose- and lactose-substituted vinyl ethers (MalVE and LacVE, respectively) and maltose-substituted maleimide (MalMI) were newly synthesized. RAFT copolymerization of MalVE and ethyl maleimide (EtMI) (monomer feed ratio: MalVE:EtMI = 1:1) afforded periodic glycopolymers (poly(MalVE-co-EtMI)) consisting of major parts of alternating structure (-(MalVE-EtMI)n-) and a small part of consecutive sequences of EtMI (⁻EtMI-EtMI-). Occurrence of the latter sequences was caused by the homopolymerizability of maleimide under the present polymerization condition, and the formation of the consecutive sequences of EtMI was successfully suppressed by varying the monomer feed ratio. RAFT copolymerization of LacVE and EtMI was also found to proceed and similarly yielded periodic glycopolymers (poly(LacVE-co-EtMI)). Moreover, RAFT copolymerization of LacVE and MalMI (monomer feed ratio: LacVE:MalMI = 1:1) was performed to give copolymers (poly(LacVE-co-MalMI)) having composition ratio of LacVE/MalMI ≈ 36/64. The resultant periodic glycopolymers poly(MalVE-co-EtMI) and poly(LacVE-co-EtMI) were subjected to lectin binding assay using concanavalin A and peanut agglutinin, exhibiting the glycocluster effect. Moreover, these glycopolymers obtained from the copolymerization of VE and MI were found to be non-cytotoxic.Entities:
Keywords: CuAAC click reaction; RAFT copolymerization; alternating glycopolymer; carbohydrate-substituted maleimide; carbohydrate-substituted vinyl ether; glycosaminoglycan mimics; periodic glycopolymer
Year: 2019 PMID: 30960054 PMCID: PMC6401991 DOI: 10.3390/polym11010070
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Figure 1Concept of glycosaminoglycan mimicking in this study.
Figure 2Time–monomer conversion curves for the RAFT copolymerization of MalVE and EtMI with BTSE.
Figure 3(a) SEC curves of poly(MalVE-co-EtMI) using 0.2 mol·L−1 NaNO3 aq. as the eluent; and (b) experimentally observed Mn and Mw/Mn value of poly(MalVE-co-EtMI) plotted against theoretical Mn of poly(MalVE-co-EtMI). Filled circles and squares correspond to the Mn data obtained by 1H NMR and SEC, respectively.
Figure 41H NMR spectrum of poly(MalVE-co-EtMI) in D2O.
RAFT copolymerization of MalVE and EtMI 1.
| Reaction Time (min) | Conversion (%) 2 |
|
| Composition Ratio (%) 1 | |||
|---|---|---|---|---|---|---|---|
| MalVE | EtMI | MalVE | EtMI | ||||
| 15 | 24 | 39 | 2100 | 9600 | 1.34 | 41 | 59 |
| 30 | 40 | 66 | 3100 | 14,000 | 1.46 | 42 | 58 |
| 60 | 65 | 95 | 4200 | 24,000 | 1.49 | 40 | 60 |
| 120 | 73 | 100 | 4400 | 27,000 | 1.53 | 42 | 58 |
1 Polymerization conditions: H2O/acetonitrile = 4/3 (v/v), 60 °C, [MalVE]0 + [EtMI]0 = 15 wt %, [MalVE]0/[EtMI]0/[VA-044]0/[BTSE]0 = 50/50/1/1. 2 Determined by 1H NMR. 3 Estimated by PEG-calibrated SEC.
Figure 5MALDI-TOF-MS spectrum of poly(MalVE-co-EtMI).
Figure 6Copolymer composition curve for the copolymerization of MalVE (M1) and EtMI (M2). The dotted line in plot was fitted by the Kelen–Tüdõs method, assuming that the values of r11 and r21 are 0.
RAFT copolymerization of LacVE and EtMI 1.
| Reaction Time (min) | Conversion (%) 2 |
|
| Composition Ratio (%) 1 | |||
|---|---|---|---|---|---|---|---|
| LacVE | EtMI | LacVE | EtMI | ||||
| 10 | 28 | 37 | 3600 | 10,000 | 1.46 | 43 | 57 |
| 20 | 49 | 66 | 4600 | 22,000 | 1.49 | 42 | 58 |
| 40 | 75 | 92 | 6200 | 29,000 | 1.53 | 43 | 57 |
| 80 | 87 | 100 | 6600 | 28,000 | 1.51 | 43 | 57 |
1 Polymerization conditions: H2O/acetonitrile = 4/3 (v/v), 60 °C, [LacVE]0 + [EtMI]0 = 15 wt %, [LacVE]0/[EtMI]0/[VA-044]0/[BTSE]0 = 50/50/1/1. 2 Determined by 1H NMR. 3 Estimated by PEG-calibrated SEC.
RAFT copolymerization of LacVE and MalMI 1.
| Reaction Time (min) | Conversion (%) 2 |
| Composition Ratio (%) 2 | |||
|---|---|---|---|---|---|---|
| LacVE | MalMI | LacVE | MalMI | |||
| 20 | 3 | 22 | 4700 | 1.40 | 36 | 64 |
| 30 | 18 | 34 | 5000 | 1.48 | 35 | 65 |
| 60 | 30 | 49 | 5800 | 1.52 | 36 | 64 |
| 120 | 61 | 74 | 5900 | 1.50 | 36 | 64 |
| 240 | 67 | 81 | 6000 | 1.47 | 36 | 64 |
1 Polymerization conditions: H2O/acetonitrile = 4/3 (v/v), 60 °C, [LacVE]0 + [MalMI]0 = 10 wt %, [LacVE]0/[MalMI]0/[VA-044]0/[BTSE]0 = 50/50/1/1. 2 Determined by 1H NMR. 3 Estimated by PEG-calibrated SEC.
Figure 71H NMR spectrum of poly(LacVE-co-MalMI) in D2O.
Figure 8Quenching of the fluorescence intensity of: (a) FITC-labeled Con A by the addition of poly(MalVE-co-EtMI); and (b) FITC-labeled PNA by the addition of poly(LacVE-co-EtMI). [Maltose*] and [Lactose*] correspond to the concentration of the pendant maltose moiety in the poly(MalVE-co-EtMI) and the pendant lactose moiety in the poly(LacVE-co-EtMI), respectively.
Figure 9Cytotoxicity studies for the obtained glycopolymers. The mouse mesenchymal stem cell line (D1 cell) was treated with/without poly(MalVE-co-EtMI) or poly(LacVE-co-MalMI) for four days. The data were normalized to the control group without polymers. The results are presented as percentages (control group: 100%). Data represent the mean with standard deviation (n = 5 per group). N.S., not significant.